These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10949914)

  • 1. Interaction between the actions of taurine and angiotensin II.
    Schaffer SW; Lombardini JB; Azuma J
    Amino Acids; 2000; 18(4):305-18. PubMed ID: 10949914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of taurine depletion on angiotensin II-mediated modulation of myocardial function.
    Schaffer SW; Ballard-Croft C; Takahashi K; Azuma J
    Adv Exp Med Biol; 1998; 442():145-52. PubMed ID: 9635026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of taurine on chronic heart failure: actions of taurine against catecholamine and angiotensin II.
    Ito T; Schaffer S; Azuma J
    Amino Acids; 2014 Jan; 46(1):111-9. PubMed ID: 23722414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of taurine on signal transduction steps induced during hypertrophy of rat heart myocytes.
    Rao MR; Tao L
    Adv Exp Med Biol; 1998; 442():137-43. PubMed ID: 9635025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taurine attenuates hypertrophy induced by angiotensin II in cultured neonatal rat cardiac myocytes.
    Azuma M; Takahashi K; Fukuda T; Ohyabu Y; Yamamoto I; Kim S; Iwao H; Schaffer SW; Azuma J
    Eur J Pharmacol; 2000 Sep; 403(3):181-8. PubMed ID: 10973617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taurine improves angiotensin II-induced hypertrophy of cultured neonatal rat heart cells.
    Takahahsi K; Azuma M; Baba A; Schaffer S; Azuma J
    Adv Exp Med Biol; 1998; 442():129-35. PubMed ID: 9635024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Taurine as a regulator of fluid-electrolyte balance and arterial pressure].
    Ciechanowska B
    Ann Acad Med Stetin; 1997; 43():129-42. PubMed ID: 9471912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of a Na+-H+ exchange inhibitor ethylisopropylamiloride, a Na+-Ca2+ exchange inhibitor KB-R7943 and their combination on the increases in contractility and Ca2+ transient induced by angiotensin II in isolated adult rabbit ventricular myocytes.
    Fujita S; Endoh M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):575-84. PubMed ID: 10598797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive inotropic effect of angiotensin II. Increases in intracellular Ca2+ or changes in myofilament Ca2+ responsiveness?
    Mattiazzi A
    J Pharmacol Toxicol Methods; 1997 Jun; 37(4):205-14. PubMed ID: 9279776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taurine indirectly increases [Ca]i by inducing Ca2+ influx through the Na(+)-Ca2+ exchanger.
    Bkaily G; Jaalouk D; Sader S; Shbaklo H; Pothier P; Jacques D; D'Orléans-Juste P; Cragoe EJ; Bose R
    Mol Cell Biochem; 1998 Nov; 188(1-2):187-97. PubMed ID: 9823024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taurine Prevents Angiotensin II-Induced Human Endocardial Endothelium Morphological Remodeling and the Increase in Cytosolic and Nuclear Calcium and ROS.
    Jacques D; Bkaily G
    Nutrients; 2024 Mar; 16(5):. PubMed ID: 38474873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of long-term treatment of imidapril on mortality, cardiac function, and gene expression in congestive heart failure due to myocardial infarction.
    Ren B; Shao Q; Ganguly PK; Tappia PS; Takeda N; Dhalla NS
    Can J Physiol Pharmacol; 2004 Dec; 82(12):1118-27. PubMed ID: 15644955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin-1 and angiotensin II receptors in cells from rat hypertrophied heart. Receptor regulation and intracellular Ca2+ modulation.
    Fareh J; Touyz RM; Schiffrin EL; Thibault G
    Circ Res; 1996 Feb; 78(2):302-11. PubMed ID: 8575074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of taurine on angiotensin II-induced hypertrophy of neonatal rat cardiac cells.
    Takahashi K; Azuma M; Taira K; Baba A; Yamamoto I; Schaffer SW; Azuma J
    J Cardiovasc Pharmacol; 1997 Dec; 30(6):725-30. PubMed ID: 9436809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congestive heart failure--pathophysiology and medical treatment.
    Remme WJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S36-52. PubMed ID: 2422492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II in the failing heart. Short communication.
    Schulz R; Heusch G
    Kidney Blood Press Res; 2005; 28(5-6):349-52. PubMed ID: 16534230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced angiotensin II activity in heart failure: reevaluation of the counterregulatory hypothesis of receptor subtypes.
    Opie LH; Sack MN
    Circ Res; 2001 Apr; 88(7):654-8. PubMed ID: 11304486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible cause of taurine-deficient cardiomyopathy: potentiation of angiotensin II action.
    Schaffer S; Solodushko V; Pastukh V; Ricci C; Azuma J
    J Cardiovasc Pharmacol; 2003 May; 41(5):751-9. PubMed ID: 12717106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial natriuretic factor in taurine-treated normal and cardiomyopathic hamsters.
    Dlouha H; McBroom MJ
    Proc Soc Exp Biol Med; 1986 Mar; 181(3):411-5. PubMed ID: 2935882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neuroendocrinology of congestive heart failure.
    Opie LH
    Cardiovasc J S Afr; 2002; 13(4):171-8. PubMed ID: 12389058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.